Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-26 @ 1:41 AM
Study NCT ID:
NCT04486833
Status:
RECRUITING
Last Update Posted:
2025-11-05
First Post:
2020-07-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Sponsor:
Genprex, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-03
Start Date Type:
ACTUAL
Primary Completion Date:
2028-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-22
First Submit QC Date:
None
Study First Post Date:
2020-07-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-04
Last Update Post Date:
2025-11-05
Last Update Post Date Type:
ESTIMATED